Auvi-Q Pen Injector Recall

Posted in Latest News on November 2, 2015.

Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving drug.

The recall includes all Auvi-Q injections currently on the U.S. market, or roughly 490,000 packs of the devices, the company says. Most packs include two injectors.

Sanofi’s product competes with Mylan’s EpiPen, which is a staple of first-aid care. Both products are used to treat allergic reactions caused from insect bites, foods, medicines or other substances.

About 200,000 people in the U.S. have Sanofi’s injector, according to company estimates.

Consumers can call 1-866-726-6340 or visit the product’s website for information on how to return the injector. They should also contact their health provider to get a prescription for an alternate device.

flbn4



More Latest News

NCSBN joins with other nursing stakeholders to support practice/academic partnerships to assist with COVID-19
March 26, 2020

Please click here to view the Policy Brief.


Important Message Regarding License Expiration Dates
March 22, 2020

Governor Ron DeSantis extended the licensure renewal expiration date for all health care practitioners currently in licensure renewal. Continue reading




Need to Verify a License?

To verify a Nurse Licensure Compact Multi-State RN or LPN License:
Access https://www.nursys.com and click on "Look up License".

 

To proceed to the DOH License Verification page (information on Florida licensees only), click here.